Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Saraceno

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2014
Riboflavin and migraine: the bridge over troubled mitochondriaBruno Colombo, Lorenzo Saraceno, Giancarlo Comi
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 23, 2017
Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case reportLorenzo Saraceno, Vito A G Ricigliano, Michele Cavalli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2022
Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disordersLorenzo Saraceno, Fiammetta Pirro, Rosa Stigliano, et al.
Journal of Neuroimmunology|May 18, 2024
As time goes by: Treatment challenges in elderly people with multiple sclerosisStefano Gelibter, Lorenzo Saraceno, Fiammetta Pirro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 10, 2022
Delayed post-hypoxic leukoencephalopathy following opioid intoxicationFrancesco Brovelli, Lorenzo Saraceno, Andrea Di Pietro, et al.
Journal of Neurovirology|September 15, 2017
Slowly progressing varicella zoster brainstem encephalitis complicating Ramsay Hunt syndrome in an immunocompetent patient: case report and review of the literatureVito A G Ricigliano, Lorenzo Saraceno, Michele Cavalli, et al.
European Journal of Neurology|November 18, 2024
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta-analysisStefano Gelibter, Lorenzo Saraceno, Emanuela Susani, et al.
Frontiers in Neuroscience|February 9, 2018
MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature ReviewVito A G Ricigliano, Barbara Fossati, Lorenzo Saraceno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 25, 2021
SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literatureLorenzo Saraceno, Emanuela Laura Susani, Maria Raffaella Marazzi, et al.
Journal of Neuroimmunology|September 17, 2023
Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experienceStefano Gelibter, Fiammetta Pirro, Lorenzo Saraceno, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 29, 2014
Riboflavin and migraine: the bridge over troubled mitochondriaBruno Colombo, Lorenzo Saraceno, Giancarlo Comi
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 23, 2017
Posterior reversible encephalopathy syndrome after long-term treatment with low-dose sunitinib: a case reportLorenzo Saraceno, Vito A G Ricigliano, Michele Cavalli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 28, 2022
Acute idiosyncratic liver injury after Cladribine treatment for multiple sclerosis: first case report and review on associated hepatic disordersLorenzo Saraceno, Fiammetta Pirro, Rosa Stigliano, et al.
Journal of Neuroimmunology|May 18, 2024
As time goes by: Treatment challenges in elderly people with multiple sclerosisStefano Gelibter, Lorenzo Saraceno, Fiammetta Pirro, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 10, 2022
Delayed post-hypoxic leukoencephalopathy following opioid intoxicationFrancesco Brovelli, Lorenzo Saraceno, Andrea Di Pietro, et al.
Journal of Neurovirology|September 15, 2017
Slowly progressing varicella zoster brainstem encephalitis complicating Ramsay Hunt syndrome in an immunocompetent patient: case report and review of the literatureVito A G Ricigliano, Lorenzo Saraceno, Michele Cavalli, et al.
European Journal of Neurology|November 18, 2024
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta-analysisStefano Gelibter, Lorenzo Saraceno, Emanuela Susani, et al.
Frontiers in Neuroscience|February 9, 2018
MSA Mimic? Rare Occurrence of Anti-Hu Autonomic Failure and Thymoma in a Patient with Parkinsonism: Case Report and Literature ReviewVito A G Ricigliano, Barbara Fossati, Lorenzo Saraceno, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 25, 2021
SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literatureLorenzo Saraceno, Emanuela Laura Susani, Maria Raffaella Marazzi, et al.
Journal of Neuroimmunology|September 17, 2023
Tixagevimab and cilgavimab use in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder during anti-CD20 treatment: A single-center experienceStefano Gelibter, Fiammetta Pirro, Lorenzo Saraceno, et al.
Pageof 2